Osiris Therapeutics, Inc.
(NASDAQ : OSIR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. -2.71%28.4014.1%$167.11m
AMRNAmarin Corp. Plc -2.60%20.221.7%$161.85m
AXSMAxsome Therapeutics, Inc. -2.92%85.201.9%$90.60m
BHCBausch Health Cos., Inc. -2.71%28.400.0%$84.60m
GWPHGW Pharmaceuticals Plc -1.20%114.516.2%$73.62m
JAZZJazz Pharmaceuticals Plc -2.25%145.742.3%$63.95m
PRGOPerrigo Co. Plc -1.24%58.746.8%$63.73m
ICPTIntercept Pharmaceuticals, Inc. -3.02%96.6516.9%$61.51m
SAVACassava Sciences, Inc. -7.18%7.180.0%$60.84m
SAGESAGE Therapeutics, Inc. -3.46%68.028.6%$58.61m
HZNPHorizon Therapeutics Plc -2.83%36.066.6%$56.41m
MNKMallinckrodt Plc -7.68%5.1720.9%$43.68m
ICLRICON plc 0.09%174.954.2%$39.55m
CTLTCatalent, Inc. 0.05%61.602.4%$37.97m
UTHRUnited Therapeutics Corp. -1.70%89.3314.3%$34.80m

Company Profile

Osiris Therapeutics, Inc. is a stem cell company, which focuses on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular, orthopedic and wound healing markets. The company operates its business through two segments: Therapeutics and Biosurgery segment. The Therapeutics segment focuses on developing biologic stem cell drug candidates from readily available and non-controversial sources.